明晟公司MSCI北欧国家指数微幅上涨，报363.69点，北欧医疗保健板块领跑。中枢神经系统障碍、心血管疾病、泌尿障碍等疗法供应商Orion Oyj赫尔辛基股价涨4.1%，领跑一众成分股。这家芬兰公司宣布，其合作伙伴MSD已经将Opevesostat临床开发项目扩大至包括（一系列）女性癌症。

Core Viewpoint - MSCI Nordic Countries Index experienced a slight increase, closing at 363.69 points, with the healthcare sector leading the gains [1] Group 1: Company Performance - Orion Oyj, a supplier of therapies for central nervous system disorders, cardiovascular diseases, and urological disorders, saw its Helsinki stock price rise by 4.1%, outperforming other constituents [1] - The Finnish company announced that its partner MSD has expanded the clinical development project for Opevesostat to include a range of female cancers [1]